FDA - October 15, 2020 - According to a press announcement from the U.S. Food and Drug Administration, published a new Drug Safety Communication requiring labeling revisions for all nonsteroidal anti-inflammatory drugs (also known as NSAIDs). These label modifications will include a new warning to pregnant women alerting them of a … [Read more...] about NSAIDs Oligohydramnios Fetal Injury and Stillbirth Lawsuit Lawyers